|
Re: NFK meeting
|
4
|
Resverlogix Corp.
|
Feb 19, 2020 03:35PM
|
|
Re: NFK meeting
|
2
|
Resverlogix Corp.
|
Feb 19, 2020 03:37PM
|
|
Re: NFK meeting
|
2
|
Resverlogix Corp.
|
Feb 19, 2020 04:18PM
|
|
Re: NFK meeting
|
3
|
Resverlogix Corp.
|
Feb 19, 2020 05:19PM
|
|
Re: NFK meeting
|
2
|
Resverlogix Corp.
|
Feb 19, 2020 06:56PM
|
|
Re: NFK meeting
|
2
|
Resverlogix Corp.
|
Feb 20, 2020 07:35AM
|
|
What part of Cardio Dimentia group had Alzheimers
|
2
|
Resverlogix Corp.
|
Feb 20, 2020 07:38AM
|
|
Possible FDA already has eGFR information
|
3
|
Resverlogix Corp.
|
Feb 20, 2020 07:43AM
|
|
Re: NFK meeting
|
3
|
Resverlogix Corp.
|
Feb 20, 2020 08:19AM
|
|
Re: NFK meeting
|
1
|
Resverlogix Corp.
|
Feb 20, 2020 08:41AM
|
|
Re: NFK meeting
|
3
|
Resverlogix Corp.
|
Feb 20, 2020 09:14AM
|
|
Re: NFK meeting
|
2
|
Resverlogix Corp.
|
Feb 20, 2020 09:53AM
|
|
Re: NFK meeting
|
3
|
Resverlogix Corp.
|
Feb 20, 2020 10:18AM
|
|
Re: NFK meeting
|
3
|
Resverlogix Corp.
|
Feb 20, 2020 10:49AM
|
|
Re: NFK meeting
|
4
|
Resverlogix Corp.
|
Feb 20, 2020 11:22AM
|
|
Re: NFK meeting
|
2
|
Resverlogix Corp.
|
Feb 20, 2020 12:26PM
|
|
Re: NFK meeting
|
2
|
Resverlogix Corp.
|
Feb 20, 2020 12:29PM
|
|
Re: A pivotal moment’: Canadian-developed drug shows dramatic outcomes in reducing damage caused by strokes
|
3
|
Resverlogix Corp.
|
Feb 21, 2020 09:48AM
|
|
Re: H1 2020 Potential Events
|
5
|
Resverlogix Corp.
|
Feb 22, 2020 07:22AM
|
|
Re: Why is pps where it is
|
2
|
Resverlogix Corp.
|
Feb 24, 2020 07:32AM
|
